Rebates In Part D: HHS Argues Scrutiny Of Impact On Formularies, Beneficiaries Not Needed Now

 
• By Cathy Kelly

New GAO recommendations springing from recent Medicare Part D cost and access trends related to rebates may not be relevant going forward because the IRA price negotiation program and benefit redesign will significantly change the landscape, HHS says.

GAO Digs Into A Hot Topic • Source: Shutterstock

More from Market Access

More from Pink Sheet